As doctors and other health officials around the world race to find treatments and a possible cure for the novel Coronavirus, two drugs have jumped to the front of the conversation: chloroquine and hydroxychloroquine.

Recent news is indicating that the state of New York moved to begin trials Tuesday, procuring 70,000 doses of hydroxychloroquine and 750,000 doses of chloroquine.
Furthermore, the drug maker Bayer, has donated approximately 3 million doses of Resochin, its brand name for chloroquine, to the US federal government.

With Pharma14's global medicine and pricing database you can track and locate all Marketing Authorizations and manufacturers of these two important molecules globally.


Pharma14 Sample Chloroquine Germany data: